A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC).
第一作者:
Heather A,Wakelee
第一单位:
Division of Oncology, Department of Medicine, Stanford University and Stanford Cancer Institute, 875 Blake Wilbur Drive, Stanford, CA 94305-5826, USA. hwakelee@Stanford.edu
作者:
主题词
投药, 口服(Administration, Oral);成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);顺铂(Cisplatin);剂量效应关系, 药物(Dose-Response Relationship, Drug);用药计划表(Drug Administration Schedule);药物相互作用(Drug Interactions);女(雌)性(Female);人类(Humans);降血脂药物(Hypolipidemic Agents);输注, 静脉内(Infusions, Intravenous);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);维甲类X受体(Retinoid X Receptors);四氢萘类(Tetrahydronaphthalenes);长春碱(Vinblastine)
DOI
10.1007/s00280-011-1771-0
PMID
22057854
发布时间
2018-12-01
- 浏览30
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



